Minimally Invasive Video-Assisted Surgery for Concomitant Ascending Aorta and Aortic Valve Replacement via Right Infra-Axillary Thoracotomy
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery · 2024
DOI: 10.1177/15569845241285872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 2024. Verfasst von Shuwei Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Heart Center, Department of Cardiovascular Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), C…. Hauptthemen laut MEDLINE: Heart Valve Prosthesis Implantation, Aortic Valve, Aorta, Thoracotomy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: General Research Program in Medicine and Health of Zhejiang Province.
Abstract (Originalsprache)
Objective
This study aims to assess the safety, efficacy, and esthetic outcomes of an innovative 4 cm right infra-axillary incision approach for concomitant ascending aorta and aortic valve replacement (AAR and AVR), with a specific focus on achieving optimal surgical outcomes while ensuring minimal visible scarring.
Methods
We retrospectively examined all elective cases of concomitant AAR and AVR surgery performed at our institution from July 2021 to June 2023. Exclusions encompassed emergency surgery, acute type A aortic dissection, active aortic valve endocarditis, redo cardiac surgery, the necessity for concurrent mitral valve replacement, or left ventricular assist device implantation. We collected and analyzed perioperative data for the patients.
Results
The study comprised 24 consecutive patients. Cardiopulmonary bypass time and aortic cross-clamp time averaged 215.0 (interquartile range [IQR], 38.0) and 158.0 (IQR, 37.0) min, respectively. No instances of reoperation due to postoperative bleeding or need for permanent pacemaker implantation were recorded. Initial 24-h postoperative drainage volume averaged 186.9 ± 76.9 mL. Average follow-up duration was 21.7 ± 6.2 months (range, 5 to 30 months). Throughout short-term follow-up, no occurrences of valve dysfunction, paravalvular leak, cardiovascular events necessitating readmission, or mortality were observed.
Conclusions
The right infra-axillary incision approach effectively yields secure, successful, and cosmetically pleasing outcomes for concomitant AAR and AVR. Further research and comparisons are warranted to validate these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Heart Center, Department of Cardiovascular Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), China.
Förderung
- General Research Program in Medicine and Health of Zhejiang Province
Zitieren
APA
Wang, S., Luo, C., Zhou, B., Hu, Z., Liu, Z., Han, E., Wu, C., Mei, F., Lu, X., Chen, W., Dong, Z., & Cui, Y. (2024). Minimally Invasive Video-Assisted Surgery for Concomitant Ascending Aorta and Aortic Valve Replacement via Right Infra-Axillary Thoracotomy. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. https://doi.org/10.1177/15569845241285872
Vancouver
Wang S, Luo C, Zhou B, Hu Z, Liu Z, Han E, et al. Minimally Invasive Video-Assisted Surgery for Concomitant Ascending Aorta and Aortic Valve Replacement via Right Infra-Axillary Thoracotomy. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 2024. doi:10.1177/15569845241285872
BibTeX
@article{Wang2024,
author = {Wang, Shuwei and Luo, Chentao and Zhou, Bing and Hu, Zhibin and Liu, Zhifang and Han, Erlei and Wu, Changhao and Mei, Fuyang and Lu, Xiaofeng and Chen, Weikang and Dong, Zhiqiang and Cui, Yong},
title = {Minimally Invasive Video-Assisted Surgery for Concomitant Ascending Aorta and Aortic Valve Replacement via Right Infra-Axillary Thoracotomy},
journal = {Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery},
year = {2024},
doi = {10.1177/15569845241285872}
}
EUVIMED